Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR17333
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Mao, Yuxin; Senic-Matuglia, Francesca; Di Fiore, Pier Paolo; Polo, Simona; Hodsdon, Michael; De Camilli, Pietro. "Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain." Proc. Natl. Acad. Sci. U.S.A. 102, 12700-12705 (2005).
PubMed: 16118278
Assembly members:
JD, polymer, 190 residues, Formula weight is not available
UB, polymer, 76 residues, Formula weight is not available
Natural source: Common Name: Human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pGEX-6P-1 and pET43
Entity Sequences (FASTA):
JD: GPLGSMESIFHEKQEGSLCA
QHCLNNLLQGEYFSPVELSS
IAHQLDEEERMRMAEGGVTS
EDYRTFLQQPSGNMDDSGFF
SIQVISNALKVWGLELILFN
SPEYQRLRIDPINERSFICN
YKEHWFTVRKLGKQWFNLNS
LLTGPELISDTYLALFLAQL
QQEGYSIFVVKGDLPDCEAD
QLLQMIRVQQ
UB: MQIFVKTLTGKTITLEVEPS
DTIENVKAKIQDKEGIPPDQ
QRLIFAGKQLEDGRTLSDYN
IQKESTLHLVLRLRGG
Data type | Count |
binding constants | 4 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | JD | 1 |
2 | UB | 2 |
Entity 1, JD 190 residues - Formula weight is not available
1 | GLY | PRO | LEU | GLY | SER | MET | GLU | SER | ILE | PHE | |
2 | HIS | GLU | LYS | GLN | GLU | GLY | SER | LEU | CYS | ALA | |
3 | GLN | HIS | CYS | LEU | ASN | ASN | LEU | LEU | GLN | GLY | |
4 | GLU | TYR | PHE | SER | PRO | VAL | GLU | LEU | SER | SER | |
5 | ILE | ALA | HIS | GLN | LEU | ASP | GLU | GLU | GLU | ARG | |
6 | MET | ARG | MET | ALA | GLU | GLY | GLY | VAL | THR | SER | |
7 | GLU | ASP | TYR | ARG | THR | PHE | LEU | GLN | GLN | PRO | |
8 | SER | GLY | ASN | MET | ASP | ASP | SER | GLY | PHE | PHE | |
9 | SER | ILE | GLN | VAL | ILE | SER | ASN | ALA | LEU | LYS | |
10 | VAL | TRP | GLY | LEU | GLU | LEU | ILE | LEU | PHE | ASN | |
11 | SER | PRO | GLU | TYR | GLN | ARG | LEU | ARG | ILE | ASP | |
12 | PRO | ILE | ASN | GLU | ARG | SER | PHE | ILE | CYS | ASN | |
13 | TYR | LYS | GLU | HIS | TRP | PHE | THR | VAL | ARG | LYS | |
14 | LEU | GLY | LYS | GLN | TRP | PHE | ASN | LEU | ASN | SER | |
15 | LEU | LEU | THR | GLY | PRO | GLU | LEU | ILE | SER | ASP | |
16 | THR | TYR | LEU | ALA | LEU | PHE | LEU | ALA | GLN | LEU | |
17 | GLN | GLN | GLU | GLY | TYR | SER | ILE | PHE | VAL | VAL | |
18 | LYS | GLY | ASP | LEU | PRO | ASP | CYS | GLU | ALA | ASP | |
19 | GLN | LEU | LEU | GLN | MET | ILE | ARG | VAL | GLN | GLN |
Entity 2, UB 76 residues - Formula weight is not available
1 | MET | GLN | ILE | PHE | VAL | LYS | THR | LEU | THR | GLY | ||||
2 | LYS | THR | ILE | THR | LEU | GLU | VAL | GLU | PRO | SER | ||||
3 | ASP | THR | ILE | GLU | ASN | VAL | LYS | ALA | LYS | ILE | ||||
4 | GLN | ASP | LYS | GLU | GLY | ILE | PRO | PRO | ASP | GLN | ||||
5 | GLN | ARG | LEU | ILE | PHE | ALA | GLY | LYS | GLN | LEU | ||||
6 | GLU | ASP | GLY | ARG | THR | LEU | SER | ASP | TYR | ASN | ||||
7 | ILE | GLN | LYS | GLU | SER | THR | LEU | HIS | LEU | VAL | ||||
8 | LEU | ARG | LEU | ARG | GLY | GLY |